Live feed21:32:04·7mINSIDERFilingvia QuantisnowChief Executive Officer Turtle Cameron sold $1,315,346 worth of shares (15,000 units at $87.69) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 582,540 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.SYRE· Spyre Therapeutics Inc.Health CareOriginal source